Tag | Content |
---|
EnhancerAtlas ID | HS116-00316 |
Organism | Homo sapiens |
Tissue/cell | Left_ventricle |
Coordinate | chr1:11967940-11970200 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nkx3-2 | MA0122.3 | chr1:11968331-11968344 | TTTAAGTGTTTTA | - | 6.33 | ZNF143 | MA0088.2 | chr1:11967995-11968011 | TACCCACAATGCATTG | + | 9.63 | ZNF143 | MA0088.2 | chr1:11970183-11970199 | CAATGCATTGTGGGTA | - | 9.63 | Zfx | MA0146.2 | chr1:11969285-11969299 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_04401 | chr1:11967802-11970392 | Brain_Anterior_Caudate | SE_05426 | chr1:11967459-11970702 | Brain_Cingulate_Gyrus | SE_06308 | chr1:11966827-11970789 | Brain_Hippocampus_Middle | SE_07453 | chr1:11967402-11970810 | Brain_Hippocampus_Middle_150 | SE_08423 | chr1:11967438-11970628 | Brain_Inferior_Temporal_Lobe | SE_10739 | chr1:11967490-11970531 | CD19_Primary | SE_13010 | chr1:11967686-11969397 | CD34_Primary_RO01480 | SE_13010 | chr1:11969509-11970356 | CD34_Primary_RO01480 | SE_13630 | chr1:11967645-11970731 | CD34_Primary_RO01536 | SE_14236 | chr1:11967710-11969205 | CD34_Primary_RO01549 | SE_14236 | chr1:11969377-11970343 | CD34_Primary_RO01549 | SE_14675 | chr1:11967367-11971255 | CD4_Memory_Primary_7pool | SE_16078 | chr1:11967699-11970381 | CD4_Naive_Primary_7pool | SE_16518 | chr1:11967714-11970388 | CD4_Naive_Primary_8pool | SE_21206 | chr1:11967365-11970416 | CD8_Memory_7pool | SE_21842 | chr1:11967413-11970668 | CD8_Naive_7pool | SE_22216 | chr1:11967346-11970790 | CD8_Naive_8pool | SE_34570 | chr1:11966817-11970548 | HCT-116 | SE_40308 | chr1:11967553-11971272 | K562 | SE_54351 | chr1:11967622-11970499 | Spleen | SE_66899 | chr1:11967081-11970418 | H2171 | SE_67244 | chr1:11967631-11970544 | MM1S | SE_67657 | chr1:11967812-11970390 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AACCATTTAA GGTATTTCCT GAAACTGGAG CGTGATTGGT GAGACTTTAT TTGCATACCC 60 ACAATGCATT GCGCACTAAA TAATGTTCGT CTTTAAAATT ATTTCCCCTT TTTCCTTCAA 120 CATATCTTTC TCGGAACCGA GATTGCTGTC CCAGAATTGT CTGAAGAAAA AGGCTGAAGT 180 CAATAGCTCT TTTGGGCCGA AGGAAAGTTA CCATTACCCG TTTAGGAGTA GCCGTTACCT 240 GAGAACTGTA GTGTCGACGA CTGATGTTAT ACTCTGGTTT CTCTTCAAAT CGTATAAATC 300 TTTCGCCTTT TACTAAAGAT TTCCGTGGAG AGAAACGAGT GTGAGTCTGA AACCAATTTT 360 TTGAGGCCTT GCGTTTCTTA GCAGGGCTTA TTTTAAGTGT TTTAAAAACA GATGCGATTC 420 CGTTAAATCG CGTGTGGAGC TATGTAAAGT GTATTATAGA ACAAATGCGA GTTACGGTTT 480 TTCAGCTTTT CGCTTTGTTA AGGTATGTGA TATCAATTGT ATTGCATTTC TGAGCAGTTA 540 TAATATTAAG ATGTTGGGGT GGCTTACTGC TTTTGACCAA GAAGTAGGGT TTGTTGGTTG 600 ATTACACCAG TGGTTTTTAA CCCCAGCCAC TGAGTGATGG AGGGTTACCG ACTCACAAGC 660 GAGCATTAAC GCCTGAGGTC CGCCTGCTGT CAGGGCAGCA AGGCATCAGA TTCTCCTAGG 720 AGCGGGAACC CTATTGTGAA CTGCGTATAC GAGGTATCTA GGTGCGTGCT CCTTTTAAGA 780 ATCTAATGGC TGATGACGAG GGGCACAGTT TCAACCTGGA ACTGTCCACA CCCCCTACCC 840 ACCTTCCCCC GCCCTTGGAA AAACTGCCTT CCATGAACTG GGTCCCTTGT GCCAGAAAGG 900 TTGGGGACCG CTGGACTATC CGATCAAATG AAGCAGGGAC TCGGGGCGAG CTCCCCCGCT 960 GCTCCCGCCG GCTTCTCCGT GTAGAATCGA AGAAGGCAGT CCCAAGGGCT CTTCTGCCCC 1020 GTATCCCCGC CTGAGGAGCG TGCCAGGCGC GCAGCTAGTC CTCCCCCGAC CCAACCGGTT 1080 TGATGAAACG CAAGAGAAAG TGAATTTTCC AGCCACTCCC ATTGGCCAGA ATTCGTCTCA 1140 GCCGCAAGGG AGGCTGGGAA GTGCAGTCAT GCCTTCAGGT AGCCGTGAGC CCTGCTAGCG 1200 ATAGGAGATT CTAGAGAGAG GTTGAGTACT GGGGAGGAAA AACTAGCAGG GTCTGTCCCA 1260 GTAAAGGAGG GAGGAAATCC ATCGCAAAAA ATCCTGACCC CCAGGCCGGG CGCGGTGGCT 1320 CACGCCTGTA ATCCCAGCAC TTTGGGAGGC CGAGGCGGGC GGATCACCTG CGGATCACCT 1380 GAGGTCAGGA GTTCGAGACT GGCCTGGCCA ACATGGAGAA ACCCCGTCTC TACTAAAAAT 1440 ACAAAAATTA GCCGGGCAGG AGGGCGCATG CCTGTAATCA CAGCCACTCG GGAGGCTGAG 1500 GCAGGAGAAT CGCTTGAACC TGGAAGGCGG AGGTTGCAGT GAACCGAGAT CGCGCCACTG 1560 CACTCGATCC TGAGCGACAG AGCGAGACTC TGTCTCAAAA AAAAAAAAAA AAAAAAAAAA 1620 AAATCTACCC CGGGCTCAGG CCCTGAAGCA GCCGCCCACA GCCCAGCCCC GCCGTGCCCC 1680 GCCGTGCCCC GCCGTGCCCC GCCGTGCCCC GCCATGCGAC TCAAAGCCCC ATTCAAGCTA 1740 CGTAGGAGGG TAAATTGTCC TTTTCCCCCA AGGCCAGCTG CTCCTCCAGA AGCCAGCTCT 1800 GGTCCTTCAG ACTCAAATAC TAGGGAACAA TGTTTTCTCT GAGTTTTGAG TGTGTTTCTT 1860 GTTTCAGAGT AAATACGAAC CGTCGTAATG GCTAAGGGCA TCTACTTTTA AAACGCTCAA 1920 ATAAGCCTTG CTAAAAAATG CAAGACCTCT AAAAAATTGG TTTAAAACTC AGAATTATTC 1980 CTCTCCACGG AAATCTTTAG TAAAAGGCGA AAGATTTATG CGATATGAAG AGAAACTAGA 2040 GTAAGAACTT CGATGAGTGG CACTCAGTTC TCAGGTAATG GCTACTCCCA ACAGGCTAAT 2100 GGTAAATTTC TTTCTGCCCA AAAGAGCTAT TGACTTCTGC CTTTTTCTTC AGACAATTCT 2160 GGAACAGCAA TCTCAGTTTC AGGAAAGATA GATTGAAGGA AAAAGGGGAC TAGTAATTTT 2220 AAAGACGAAA ATTATTTGGT GCACAATGCA TTGTGGGTAT 2260
|